Your first month on a GLP-1: what really happens, week by week

Tu primer mes con un GLP-1: lo que de verdad pasa, semana a semana

You don't need to feel sick for it to work

There is an idea going around that does real damage: that nausea is proof the medication is "working." That if you don't feel sick, nothing is happening.

That got measured. And it turned out to be false.

One analysis pooled 2,117 people treated with semaglutide 2.4 mg across the STEP 1, 2 and 3 trials, and compared those who had digestive side effects with those who had none. The two columns came out nearly identical: 9.6% to 17.1% weight loss in people without side effects, and 11.4% to 17.7% in people with them.

The researchers went further and asked how much of the effect was explained by feeling unwell. Of all the extra weight loss compared with placebo, less than one percentage point came from digestive side effects. The rest came from the mechanism, which works whether your stomach is complaining or not.

This changes how the first month feels. If you feel nothing, you are not failing. If you feel something, you are not earning bonus points. Side effects are something to manage, not a medal and not a thermometer.

Why the dose climbs so slowly

The first time you see the schedule it tends to make you impatient. The dose starts far below the one that was studied, and takes months to get to the top.

That slowness is the design, not excess caution.

The FDA-approved prescribing information for semaglutide in weight management lays out the path in four-week steps: 0.25 mg once weekly for weeks 1 through 4, then 0.5 mg for weeks 5 through 8, 1 mg for weeks 9 through 12, 1.7 mg for weeks 13 through 16, and from week 17 onward the maintenance dose. The escalation exists precisely to reduce gastrointestinal side effects at the start.

And there is a line in that same document many people don't know about, and it's worth gold: if you don't tolerate a step well, the guidance is to consider delaying the escalation for four more weeks. Staying twice as long on a dose is not a failure and does not put you out of the plan. It is an option written into the official label.

Put differently: this treatment has a brake, and the brake is allowed. What is not planned for is speeding up on your own.

Week by week: what to expect

Weeks 1 and 2

You are on the lowest dose in the schedule. For most people this is the quiet part. What you notice is usually not the weight: it's that appetite changes its tone. A lot of people describe it as food stopping its all-day background noise.

You may find you get full sooner than usual and that dinner sits heavy if you eat at your old pace. That's stomach emptying, which is now slower. Eating more slowly and stopping earlier solves much of it.

If you feel absolutely nothing in these two weeks, that's fine. It's what this dose would predict.

Weeks 3 and 4

Here comes the first step up, and with it the window where side effects cluster most. In the STEP analysis, digestive events appeared mainly during dose escalation or shortly after. They are not spread evenly across treatment: they bunch up at these moments.

What matters is that they also pass. They were described as transient. They rise when you rise, and then the body settles into the new dose.

This is also the week many people first step on the scale with real expectation. It's worth knowing now that the number at this moment settles nothing, and below we explain why.

Week 5 onward

If you got here still on the plan, you are past the stretch where most people drop out. The pattern repeats at every step: a few days of adjustment when the dose rises, then it calms again. Each time you know it better and it frightens you less.

The side effects, one by one, and what to do

These are the rates measured with semaglutide 2.4 mg versus placebo, in the analysis of 2,117 people:

Look at the placebo column before the first number alarms you. A share of these complaints happens without any medication at all, because changing how you eat unsettles anyone's stomach.

Nausea

The most common one, and the one that responds best to simple changes. Smaller portions more often, eating slowly, and leaving very greasy or very heavy meals for later on. Your stomach is emptying more slowly: fill it at the old pace and it protests.

Constipation

It usually comes from two things at once: you are eating considerably less and, without noticing, drinking less. Water through the day and fiber from actual food. If you have questions, we cover it in fiber and GLP-1.

Vomiting

Almost always shows up after eating too much or too fast on a new dose. If it repeats, it is not for enduring in silence: that is exactly the moment to speak up, because it usually means the pace of escalation needs adjusting.

What is not normal

Severe, persistent abdominal pain, especially if it radiates to your back, is not on the list of expected side effects. Vomiting that stops you keeping fluids down isn't either. Those get a same-day call.

Your part: protein, water and muscle

There is something the medication does not do for you, and month one is the best time to build it, because you are still forming the routine.

When you lose weight, part of what you lose is lean mass. A 2026 review on muscle and incretin-based therapies found that this loss is generally proportional to the amount of weight lost, and should not be read as the drug damaging muscle. It is what happens when any body gets smaller.

The same review points at what does make a difference: adequate protein and resistance exercise. Those are the two factors that come up again and again as determinants of preserving muscle while you lose weight.

It doesn't have to be complicated. Protein at every meal, and some strength work two or three times a week, even at home with your own body weight. We go into it in strength training while losing weight.

Starting this in month one is far easier than starting it in month six, once you've already lost muscle you meant to protect.

Why the first month is not the final exam

This is where most people get discouraged for no good reason.

For those first four weeks you are on 0.25 mg: the lowest dose in the whole schedule, far below the one used in the trials to measure results. Judging the treatment there is like judging a book by its dedication page.

For a sense of the real timescale: in STEP 1, with 1,961 adults, the average weight change was measured at 68 weeks, and came to −14.9% with semaglutide versus −2.4% with placebo. Sixty-eight weeks. Not four.

Is there a point where early response does say something? Yes, but later than people think. In the literature on liraglutide, one of the factors linked to greater weight loss was having lost at least 4% of starting weight by 16 weeks. Week 16, not week 4.

So if the scale barely moved by the end of month one, you don't have enough information to conclude anything. It isn't the question yet.

The uncomfortable number, and the good news inside it

Let's put the number almost nobody publishes on the table.

A study of 201,229 adults in the United States followed what happened over twelve months to people who started a GLP-1 for weight. Only 30.7% turned out to be persistent users. 19.6% stopped almost immediately and another 23.5% stopped early. Another review puts it just as bluntly: between 32% and 50% are still on treatment at twelve months, and fewer than 15% reach the target dose.

That is the real obstacle in this treatment, and it isn't the molecule. It's getting to month two, month three, and month six.

Now the other side, which is the part that matters. In a 48-week study of people who did have structured support from the start, 74.3% were still on treatment at the end, and 87.3% of them had reached the full dose. Average weight loss was 11.8%, and 14.6% among those who stayed on. Among those who stopped, 3.9%.

Read those two paragraphs together: 30.7% without support, 74.3% with it. Whether this works or not is decided far more in the follow-up than in which molecule you happened to get.

That's why we keep insisting on something that sounds less exciting than a number of pounds: what you're paying for isn't an injection, it's that somebody is checking how you're doing, adjusting the pace when your stomach complains, and answering the message when you have a question at nine at night. That doesn't come in the box.

So your expectations are the right ones

Three short things, so you go in with your feet on the ground:

• This is not a one-month treatment. The published results come from 68- and 72-week treatment, combined with lifestyle change, not instead of it.
• Nobody can promise you a number. Trial averages are averages: inside them are people who lost a great deal more and people who lost a great deal less. Individual results vary and are not guaranteed.
• Month one measures consistency, not results. The useful question at day 30 isn't how much you lost. It's whether you're still on the plan, eating protein, and have someone to ask.

Who is this NOT for?

This section does not get shortened. If you are in any of these groups, tell your physician before starting, even if it seems minor:

• If you are pregnant, trying to become pregnant, or breastfeeding.
• If you or a close family member has had medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2.
• If you have had pancreatitis.
• If you have gastroparesis or a digestive condition that slows stomach emptying. There is also an uncommon but documented complication: gastroparesis associated with the use of these medications.
• If you have active gallbladder disease.
• If you have type 1 diabetes, or type 2 on insulin or sulfonylureas: not ruled out, but it requires adjusting those other medications and monitoring, because of hypoglycemia risk.
• If you have diabetic retinopathy.
• If you have had an eating disorder. A medication that removes hunger needs different support in that case.
• If you have significant kidney or liver disease.
• If your expectation is to lose fast and stop. That is, honestly, the worst way to begin.

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. If your case suggests this isn't the right fit, we will tell you. Your trust is worth more than a sale.

GLP-1 programs with FDA-approved medications (Wegovy®, Foundayo™, Ozempic®) from $149/month, by telemedicine, in Spanish and English

Real clinical supervision, in English and Spanish, with continuous follow-up. Cancel whenever you want, in one click.

Eligibility is determined by medical evaluation. Individual results vary and are not guaranteed.

Frequently asked questions

Is it normal to feel nothing in the first month?

Yes, and it isn't a bad sign. For the first four weeks you are on the lowest dose in the schedule. And the STEP analysis showed that people without digestive side effects lost essentially the same as those who had them.

Does nausea mean it's working?

No. This was measured specifically: of all the additional weight loss versus placebo, less than one percentage point was explained by digestive side effects. The effect happens through the mechanism, not through discomfort.

How long does the nausea last?

In the analysis of 2,117 people, digestive events were transient and clustered during dose escalation or shortly after. 98.1% were mild or moderate and 99.5% were non-serious.

What do I do if I can't tolerate a dose increase?

Talk about it before quitting on your own. The FDA-approved label itself provides for delaying the increase by four more weeks. Staying longer on a step is a planned option, not a failure.

How long until I see results?

We can't give you a number or a timeline, and be wary of anyone who does. What is published is the trial design: STEP 1 measured its result at 68 weeks. Individual results vary and are not guaranteed.

Will I lose muscle?

When you lose weight you lose some lean mass, and the 2026 review on the subject found that this loss is generally proportional to the weight lost, not the drug damaging muscle. Adequate protein and resistance exercise are the two factors that help most to preserve it.

Do I need labs before starting?

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. It is not automatic and not required for everyone.

Can I drink alcohol?

That's a conversation for your physician. In practice, alcohol is among the things that sit worst in the first weeks, when the stomach empties more slowly. We cover it separately in alcohol and GLP-1.

Sources

• Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. — DOI · via PubMed
• Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. — DOI · via PubMed
• Real-World Adherence Trajectories of GLP-1 Receptor Agonists Among Adults and Paediatric Patients With Obesity. Diabetes Obes Metab. 2026. — DOI · via PubMed
• Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study. J Med Internet Res. 2026. — DOI · via PubMed
• Mollero ELM, Dozzani I, Biamonte E, et al. Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity. Nutrients. 2026;18(16):2654. — DOI · via PubMed
• Potential contributors to variation in weight-loss response to liraglutide. Obes Rev. 2023. — DOI · via PubMed
• Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes. PLoS One. 2026. — DOI · via PubMed
• U.S. Food and Drug Administration. WEGOVY (semaglutide) injection — Highlights of Prescribing Information, 2026. — accessdata.fda.gov

Your trust is worth more than a sale.

More information →

This article is informational and is not medical advice. SCTS1 does not prescribe medications. All medical care, prescriptions and treatment plans are provided by licensed physicians through our partner platform, and preparations are dispensed by licensed pharmacies. Eligibility is determined by a licensed provider through medical evaluation. The doses and escalation schedules mentioned reflect approved prescribing information and do not replace your physician's instructions; do not change your dose on your own. Individual results vary and are not guaranteed.